Publications
Langerhans Cell Histiocytosis
Reviews
Biology of Chemokines
Reviews
Books
- Nelson DS, Marano RL, Joo Y, Tian SY, Patel B, Kaplan DH, Shlomchik MJ, Stevenson K, Bronson RT, and Rollins BJ. BRAF V600E and Pten Deletion in Mice Produces a Histiocytic Disorder with Features of Langerhans Cell Histiocytosis. PLOS One. 2019 Sep 17; 14(9).
- Nelson DS, Halteren A, Quispel WT, Bos C, Bovée JV, Patel B, Badalian‐Very G, Hummelen P, Ducar M, Lin L, MacConaill LE, Egeler RM, Rollins BJ. MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes, Chromosomes and Cancer. 2015 Jun 1;54(6):361-8.
- Nelson DS, Quispel W, Badalian-Very G, van Halteren AG, van den Bos C, Bovée JV, Tian SY, Van Hummelen P, Ducar M, MacConaill LE, Egeler RM, Rollins BJ. Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood. 2014 May 15;123(20):3152-5.
- Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Flemming MD, Rollins BJ. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010 Sep 16;116(11):1919-23.
- Fleming MD, Pinkus JL, Alexander SW, Tam C, Loda M, Sallan SE, Nichols KE, Carpentieri DF, Pinkus GS, Rollins BJ. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood. 2003 Apr 1;101(7):2473-5.
Reviews
- Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 Jun 2;127(22):2672-81.
- Rollins BJ. Genomic alterations in Langerhans cell histiocytosis. Hematology/oncology clinics of North America. 2015 Oct 31;29(5):839-51.
- Berliner N, Rollins BJ. Congenital and Acquired Disorders of Macrophages and Histiocytes. Hematology/Oncology Clinics of North America. 2015 Oct;29(5):839-51.
- Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ. Pathogenesis of Langerhans cell histiocytosis. Annual Review of Pathology: Mechanisms of Disease. 2013 Jan 24;8:1-20.
- Badalian‐Very G, Vergilio JA, Degar BA, Rodriguez‐Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. British journal of haematology. 2012 Jan 1;156(2):163-72.
- Degar BA, Rollins BJ. Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one?. Disease models & mechanisms. 2009 Sep 1;2(9-10):436-9.
Biology of Chemokines
- Chen X, Wang Y, Nelson D, Tian S, Mulvey E, Patel B, Conti I, Jaen J, Rollins BJ. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice. PloS one. 2016 Nov 7;11(11):e0165595.
- Kleine‐Lowinski K, Rheinwald JG, Fichorova RN, Anderson DJ, Basile J, Münger K, Daly CM, Rösl F, Rollins BJ. Selective suppression of monocyte chemoattractant protein‐1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. International journal of cancer. 2003 Nov 10;107(3):407-15.
- Soejima K, Rollins BJ. A functional IFN-γ-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. The Journal of Immunology. 2001 Dec 1;167(11):6576-82.
- Long GU, Tseng S, Horner RM, Tam C., Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 2000 Mar 23;404(6776):407.
- Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor–deficient mice. Molecular cell. 1998 Aug 31;2(2):275-81.
- Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1–deficient mice. Journal of Experimental Medicine. 1998 Feb 16;187(4):601-8.
- Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, Rollins BJ. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. The Journal of Immunology. 1997 Jul 1;159(1):401-8.
- Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. The Journal of Immunology. 1995 Nov 15;155(10):4838-43.
- Zhang Y, Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Molecular and cellular biology. 1995 Sep 1;15(9):4851-5.
- Zhang YJ, Rutledge BJ, Rollins BJ. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis: Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. Journal of Biological Chemistry. 1994 Jun 3;269(22):15918-24.
- Ernst CA, Zhang YJ, Hancock PR, Rutledge BJ, Corless CL, Rollins BJ. Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. The Journal of Immunology. 1994 Apr 1;152(7):3541-9.
- Rollins BJ, Sunday ME. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Molecular and cellular biology. 1991 Jun 1;11(6):3125-31.
Reviews
- Rollins BJ. Where the confusion began: cloning the first chemokine receptors. The Journal of Immunology. 2009 Sep 1;183(5):2893-4.
- Rollins BJ. Innocents abroad: regulating where naive T cells go. Nature immunology. 2008 Mar 1;9(3):233-5.
- Rollins BJ. Inflammatory chemokines in cancer growth and progression. European Journal of Cancer. 2006 Apr 30;42(6):760-7.
- Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. In Seminars in cancer biology. 2004 Jun 30;14(3):149-54.
- Conti I, Dube C, Rollins BJ. Chemokine-based pathogenetic mechanisms in cancer. InNovartis Foundation symposium. 2004 Mar 5;256:29.
- Daly C, Dube C, Rollins BJ. Chemokine influences on adaptive immunity and malignancies of the immune system. In Chemokine Roles in Immunoregulation and Disease. 2004:11-30.
- Daly C, Rollins BJ. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation. 2003 Jan 1;10(3-4):247-57.
- Gerard C, Rollins BJ. Chemokines and disease. Nature immunology. 2001 Feb 1;2(2):108.
Books
- Rollins B, editor. Chemokines and cancer. Springer Science & Business Media; 1999 Apr 9.